Two-thirds of health care providers agree or strongly agree with expanding recommendations for the new 20-valent pneumococcal conjugate vaccine (PCV20), according to research published in the Sept. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
from Medical Xpress - latest medical and health news stories https://ift.tt/a9du02w
